Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter

Cancer Gene Therapy

Volumn 7, Issue 9, 2000, Pages 1241-1249

  Tanaka, Saiyu ^a   Iwai, Masaki ^a   Harada, Yoshinori ^a   Morikawa, Teruhisa ^a   Muramatsu, Akira ^a   Mori, Takahiro ^a   Okanoue, Takeshi ^a   Kashima, Kei ^a   Maruyama Tabata, Hiroko ^a   Hirai, Hideyo ^a   Satoh, Etsuko ^a   Imanishi, Jiro ^a   Mazda, Osam ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Carcinoembryonic antigen promoter; Cholangiocarcinoma; EBV encoded nuclear antigen 1; Epstein Barr virus based vector; Gene therapy; Polyamidoamine dendrimer

Indexed keywords

BETA GALACTOSIDASE; CARCINOEMBRYONIC ANTIGEN; DENDRIMER; EPSTEIN BARR VIRUS ANTIGEN; GANCICLOVIR; PLASMID VECTOR; POLYAMIDE; THYMIDINE KINASE;

ARTICLE; BILE DUCT CARCINOMA; CELL KILLING; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TANDEM REPEAT;

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4;

EID: 0033775480     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700219     Document Type: Article

References (48)

1. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma
2. Intrahepatic cholangiocarcinoma: Clinical aspects, pathology, and treatment
3. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors
4. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
5. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter
6. Gene therapy for α-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
7. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2
8. Specific carcinoembryonic antigens of the human digestive system
9. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy
10. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
11. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo
12. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma
13. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo
14. Cloning of the complete gene for carcinoembryonic antigen: Analysis of its promoter indicates a region conveying cell type-specific expression
15. In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression
16. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro
17. Selective expression of carcinoembryonic antigen promoter in cancer cell lines: Targeting strategy for gene therapy in colorectal cancer
18. Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter
19. Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors
20. Use of EBV-based vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms
21. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome
22. + cells by transfecting EBV-based episomal vectors
23. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells
24. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
25. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
26. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
27. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1
28. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene
29. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus
30. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain
31. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer
32. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer
33. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
34. 3H]thymidine incorporation assay
35. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia
36. Localization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas
37. Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers
38. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma; in situ hybridization study and implication for a new in vivo functional model
39. A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium
40. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function
41. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia
42. A strategy for specific targeting of therapeutic agents to tumor cells of virus-associated cancers
43. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: Comparison of two different Epstein-Barr virus-based vectors
44. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
45. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers
46. In vitro gene delivery by degraded polyamidoamine dendrimers
47. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes
48. Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors